EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Progesterone Receptor Membrane Component 1 to Improve Muscle Development and Glucose Homeostasis

Sang R Lee, Moeka Mukae, Globinna Kim, Jung-Eun Park, Young Hoon Sung, Young Suk Won, Tae Won Kim, Hyo-Jung Kwun, In-Jeoung Baek, Eui-Ju Hong iD

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.70121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Sang R Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Receptors, Progesterone, Membrane Proteins, Glucose, Muscle Development. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Korea government (MSIT), Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2D) arises from the interplay between peripheral insulin resistance and pancreatic β‐cell dysfunction, ultimately leading to impaired glucose utilization and chronic hyperglycemia. Despite therapeutic advances, the multifactorial nature of T2D continues to demand the development of novel treatment strategies. Progesterone receptor membrane component 1 (PGRMC1) has emerged as a potential modulator of metabolic function, though its role in T2D pathogenesis has not been fully elucidated.

Methods

To investigate the role of PGRMC1 in T2D, we generated skeletal muscle‐specific Pgrmc1 knockout (PKO) mice ( ACTA cre ‐ Pgrmc1 fl/fl ). T2D was induced via a high‐fat diet combined with streptozotocin (HFD‐STZ) or using genetically diabetic ( lepr db / lepr db ; db/db ) mice. A small‐molecule screen of 330 compounds identified 11α‐hydroxyprogesterone (11α‐OHP) as a PGRMC1‐modulating candidate. The antidiabetic efficacy of 11α‐OHP was assessed in vitro and across multiple in vivo diabetic models. Whole‐body PKO mice were used to evaluate the systemic consequences of global Pgrmc1 deletion. Glucose tolerance test (GTT), insulin tolerance test (ITT) and modified homeostatic model assessment for insulin resistance (HOMA‐IR, 5‐h fasting) were used to evaluate glucose metabolism. Real‐time cell metabolism analyser (Seahorse analysis) was used for measuring cellular glycolysis.

Results

Skeletal muscle PKO improved glucose clearance in GTT ( p < 0.0001) and insulin sensitivity in ITT ( p < 0.0001). Skeletal muscle PKO mice under T2D suppressed insulin resistance according to reduced modified HOMA‐IR ( p < 0.05) and promoted muscle development (quadriceps femoris, gastrocnemius, tibialis anterior muscle and extensor digitorum longus; p < 0.05). Mechanistically, PGRMC1 interacted with PPP2R5D, a PP2A regulatory subunit, which dephosphorylates RSK1. PGRMC1 loss suppressed PP2A activity, increasing RSK1 phosphorylation and activating AKT signalling, thereby enhancing myoblast proliferation ( p < 0.05), differentiation ( p < 0.01) and glycolysis ( p < 0.0001). 11α‐OHP facilitated proteasomal degradation of PGRMC1, elevated pAKT levels and improved glucose clearance in GTT ( p < 0.0001) and insulin sensitivity in ITT ( p < 0.0001) in wild‐type mice but not in PKO mice. Notably, 11α‐OHP restored glucose clearance in GTT ( p < 0.0001) and insulin sensitivity in ITT ( p < 0.0001) and increased muscle mass in both HFD‐STZ and db/db mice, but its effects were abolished in skeletal muscle PKO mice. Whole‐body PKO mice still increased muscle development and metabolic activation, suggesting minimal interference by systemic PKO.

Conclusions

These findings identify skeletal muscle PGRMC1 as a pivotal regulator of glucose metabolism and highlight its inhibition as a promising muscle‐targeted therapeutic approach for T2D management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, ProgesteroneMembrane ProteinsGlucoseMuscle DevelopmentMuscle, SkeletalAnimalsMiceHomeostasisDiabetes Mellitus, Type 2Mice, KnockoutMaleInsulin ResistanceDiabetes Mellitus, Experimental

Stichwörter der Autor:innen

PGRMC1glucose homeostasisinsulin resistanceskeletal muscletype 2 diabetes

Substanzen

Receptors, ProgesteroneMembrane ProteinsGlucosePGRMC1 protein, mouse

Autor:innen und Institutionen

  • College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.
  • Department of Physiology, Dong-A University College of Medicine, Busan, Republic of Korea.
  • Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan, Republic of Korea.
  • Department of Cell and Genetic Engineering, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Laboratory Animal Resource and Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.

ORCID-Profile: Eui-Ju Hong

Förderung

  • Ministry of Education
  • Korea government (MSIT)
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Lee, S. R., Mukae, M., Kim, G., Park, J. E., Sung, Y. H., Won, Y. S., Kim, T. W., Kwun, H. J., Baek, I. J., & Hong, E. J. (2025). Targeting Progesterone Receptor Membrane Component 1 to Improve Muscle Development and Glucose Homeostasis. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70121

Vancouver

Lee SR, Mukae M, Kim G, Park JE, Sung YH, Won YS, et al. Targeting Progesterone Receptor Membrane Component 1 to Improve Muscle Development and Glucose Homeostasis. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.70121

BibTeX
@article{Lee2025,
  author = {Lee, Sang R and Mukae, Moeka and Kim, Globinna and Park, Jung-Eun and Sung, Young Hoon and Won, Young Suk and Kim, Tae Won and Kwun, Hyo-Jung and Baek, In-Jeoung and Hong, Eui-Ju},
  title = {Targeting Progesterone Receptor Membrane Component 1 to Improve Muscle Development and Glucose Homeostasis},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.70121}
}
Kostenlos starten →